• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 CD14、白细胞介素-6 和降钙素原对糖尿病足溃疡患者下肢截肢的预测价值:一项初步研究。

Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study.

机构信息

Ahmet Karakas, Assistant Professor, Department of Infectious Disease and Clinical Microbiology, Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey.

Dr. Erol Arslan, Assistant Professor, Department of Medicine, Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey.

出版信息

Pak J Med Sci. 2014 May;30(3):578-82. doi: 10.12669/pjms.303.4575.

DOI:10.12669/pjms.303.4575
PMID:24948983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4048510/
Abstract

OBJECTIVE

The aim of this pilot study was to determine clinical and laboratory factors that predict amputation surgery and to evaluate the predictive value of soluble CD14 (sCD14), interleukin-6 (IL-6), and procalcitonin (PCT) in patients with diabetic foot ulcers (DFUs).

METHODS

Twenty-seven (20 males, 7 females) Diabetic Foot Ulcers (DFU) patients admitted to our department were consecutively enrolled. The patients' demographics and wound characteristics were noted. IL-6, PCT, and sCD14 were measured at admission.

RESULTS

Six of the 27 patients (22%) eventually underwent lower extremity amputation. Compared to the non-amputation group, a previous history of amputation (p=0.017), the presence of gangrene (p=0.044), the Wagner grade (p=0.011), the IL-6 concentration (p=0.018), the white blood cell count (WBC) (p=0.036), and the erythrocyte sedimentation rate (ESR) (p=0.042) were significantly high in the amputation group. However, the sCD14 and PCT concentration were not significantly different.

CONCLUSION

We have shown for the first time that IL-6 may have predictive value for lower extremity amputation in patients with DFU. Further studies are needed to confirm its predictive value in this patient group.

摘要

目的

本初步研究旨在确定预测截肢手术的临床和实验室因素,并评估可溶性 CD14(sCD14)、白细胞介素-6(IL-6)和降钙素原(PCT)在糖尿病足溃疡(DFU)患者中的预测价值。

方法

连续纳入 27 名(20 名男性,7 名女性)患有糖尿病足溃疡(DFU)的患者到我科。记录患者的人口统计学和伤口特征。入院时测量 IL-6、PCT 和 sCD14。

结果

27 名患者中有 6 名(22%)最终进行了下肢截肢。与非截肢组相比,既往截肢史(p=0.017)、坏疽存在(p=0.044)、Wagner 分级(p=0.011)、IL-6 浓度(p=0.018)、白细胞计数(WBC)(p=0.036)和红细胞沉降率(ESR)(p=0.042)在截肢组中显著升高。然而,sCD14 和 PCT 浓度没有显著差异。

结论

我们首次表明,IL-6 可能对 DFU 患者的下肢截肢具有预测价值。需要进一步的研究来证实其在该患者群体中的预测价值。

相似文献

1
Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study.可溶性 CD14、白细胞介素-6 和降钙素原对糖尿病足溃疡患者下肢截肢的预测价值:一项初步研究。
Pak J Med Sci. 2014 May;30(3):578-82. doi: 10.12669/pjms.303.4575.
2
[Characteristics of Inflammatory Markers in Diabetic Foot Patients and Their Relationship With Prognosis of Diabetic Foot Ulcers].糖尿病足患者炎症标志物的特征及其与糖尿病足溃疡预后的关系
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1233-1238. doi: 10.12182/20230960506.
3
Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.循环降钙素原作为生物标志物反映南印度糖尿病足溃疡炎症的潜力。
J Vasc Surg. 2018 Apr;67(4):1283-1291.e2. doi: 10.1016/j.jvs.2017.02.060. Epub 2017 Jul 21.
4
Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.设计不佳的研究无助于阐明高压氧在慢性糖尿病足溃疡治疗中的作用。
Diving Hyperb Med. 2016 Sep;46(3):133-134.
5
The impact of inflammatory biomarkers on amputation rates in patients with diabetic foot ulcers.炎症生物标志物对糖尿病足溃疡患者截肢率的影响。
Int Wound J. 2024 Apr;21(4):e14827. doi: 10.1111/iwj.14827.
6
Evaluation of major and minor lower extremity amputation in diabetic foot patients.糖尿病足患者大、小下肢截肢的评估
Turk J Med Sci. 2017 Aug 23;47(4):1109-1116. doi: 10.3906/sag-1601-58.
7
Procalcitonin as a Biomarker for Predicting Amputation Level in Lower Extremity Infections.降钙素原作为预测下肢感染截肢水平的生物标志物。
J Foot Ankle Surg. 2017 May-Jun;56(3):484-491. doi: 10.1053/j.jfas.2017.01.014. Epub 2017 Mar 22.
8
[Clinical Characteristics of Diabetic Patients with Initial and Recurrent Foot Ulcers].[初发和复发足部溃疡糖尿病患者的临床特征]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Nov;53(6):969-975. doi: 10.12182/20220860105.
9
Procalcitonin levels and other biochemical parameters in patients with or without diabetic foot complications.伴有或不伴有糖尿病足并发症患者的降钙素原水平及其他生化指标。
J Res Med Sci. 2017 Aug 16;22:95. doi: 10.4103/jrms.JRMS_906_16. eCollection 2017.
10
Comparative Evaluation of the Diagnostic Value of Procalcitonin and hsCRP for the Presence of Mild-to-Moderate Diabetic Foot Infections.降钙素原与超敏C反应蛋白对轻至中度糖尿病足感染诊断价值的比较评估
Int J Low Extrem Wounds. 2023 Jun;22(2):353-359. doi: 10.1177/15347346211011849. Epub 2021 Apr 28.

引用本文的文献

1
The Potential Role of Presepsin in Predicting Severe Infection in Patients with Diabetic Foot Ulcers.前降钙素原在预测糖尿病足溃疡患者严重感染中的潜在作用。
J Clin Med. 2024 Apr 17;13(8):2311. doi: 10.3390/jcm13082311.
2
[Characteristics of Inflammatory Markers in Diabetic Foot Patients and Their Relationship With Prognosis of Diabetic Foot Ulcers].糖尿病足患者炎症标志物的特征及其与糖尿病足溃疡预后的关系
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Nov 20;54(6):1233-1238. doi: 10.12182/20230960506.
3
Clinical characteristics and risk factors of lower extremity amputation in patients with diabetic foot.糖尿病足患者下肢截肢的临床特征及危险因素
Pak J Med Sci. 2022 Nov-Dec;38(8):2253-2258. doi: 10.12669/pjms.38.8.5635.
4
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection.降钙素原是合并糖尿病足感染的重症肢体缺血患者住院结局的预测标志物。
J Diabetes Res. 2019 Aug 14;2019:4312737. doi: 10.1155/2019/4312737. eCollection 2019.
5
Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?Pentraxin-3:预测糖尿病足感染严重程度的新参数?
Int Wound J. 2019 Jun;16(3):659-664. doi: 10.1111/iwj.13075. Epub 2019 Feb 15.
6
Scorpion Venom Active Polypeptide May Be a New External Drug of Diabetic Ulcer.蝎毒活性多肽可能成为糖尿病溃疡的新型外用药物。
Evid Based Complement Alternat Med. 2017;2017:5161565. doi: 10.1155/2017/5161565. Epub 2017 Oct 29.
7
Procalcitonin levels and other biochemical parameters in patients with or without diabetic foot complications.伴有或不伴有糖尿病足并发症患者的降钙素原水平及其他生化指标。
J Res Med Sci. 2017 Aug 16;22:95. doi: 10.4103/jrms.JRMS_906_16. eCollection 2017.
8
Cost of illness among patients with diabetic foot ulcer in Turkey.土耳其糖尿病足溃疡患者的疾病成本。
World J Diabetes. 2016 Oct 15;7(18):462-469. doi: 10.4239/wjd.v7.i18.462.
9
Vacuum Assisted Closure- utilization as home based therapy in the management of complex diabetic extremity wounds.负压封闭引流技术——作为复杂糖尿病肢体伤口居家治疗手段的应用
Pak J Med Sci. 2015 Jan-Feb;31(1):95-9. doi: 10.12669/pjms.311.6093.

本文引用的文献

1
Reamputation after minor foot amputation in diabetic patients: risk factors leading to limb loss.糖尿病患者足部小截肢后的再次截肢:导致肢体丧失的危险因素。
J Foot Ankle Surg. 2013 Mar-Apr;52(2):184-7. doi: 10.1053/j.jfas.2012.11.015.
2
Screening for the high-risk diabetic foot: a 60-second tool (2012).筛查高危糖尿病足:一种 60 秒工具(2012 年)。
Adv Skin Wound Care. 2012 Oct;25(10):465-76; quiz 477-8. doi: 10.1097/01.ASW.0000421460.21773.7b.
3
Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study.治疗是否会影响糖尿病足感染患者血清白细胞介素-6、白细胞介素-8 和降钙素原的水平?一项初步研究。
J Diabetes Complications. 2012 May-Jun;26(3):214-8. doi: 10.1016/j.jdiacomp.2012.03.018. Epub 2012 Apr 20.
4
Predictive factors for lower extremity amputations in diabetic foot infections.糖尿病足感染患者下肢截肢的预测因素
Diabet Foot Ankle. 2011;2. doi: 10.3402/dfa.v2i0.7463. Epub 2011 Sep 20.
5
Risk factors for lower extremity amputation in diabetic foot disease categorized by Wagner classification.糖尿病足病 Wagner 分级分类的下肢截肢风险因素。
Diabetes Res Clin Pract. 2012 Mar;95(3):358-63. doi: 10.1016/j.diabres.2011.10.034. Epub 2011 Nov 23.
6
Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers.新生儿败血症中的可溶性CD14亚型前降钙素原(sCD14-ST)和脂多糖结合蛋白(LBP):两种旧生物标志物的新临床与分析视角
J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:12-4. doi: 10.3109/14767058.2011.601923.
7
CD14 modulates inflammation-driven insulin resistance.CD14 调节炎症驱动的胰岛素抵抗。
Diabetes. 2011 Aug;60(8):2179-86. doi: 10.2337/db10-1210. Epub 2011 Jun 23.
8
Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.脂联素、抵抗素和白细胞介素-6 血浆水平在糖尿病足患者中的变化及其与临床变量和心血管合并症的相关性。
Cardiovasc Diabetol. 2010 Sep 13;9:50. doi: 10.1186/1475-2840-9-50.
9
[Change of serum soluble CD14 level in newly diagnosed type 2 diabetes and its significance].新诊断2型糖尿病患者血清可溶性CD14水平的变化及其意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;35(7):699-704. doi: 10.3969/j.issn.1672-7347.2010.07.009.
10
Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.足部综合检查与风险评估:美国糖尿病协会足部护理兴趣小组特别工作组报告,获美国临床内分泌医师协会认可
Diabetes Care. 2008 Aug;31(8):1679-85. doi: 10.2337/dc08-9021.